Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Ovarian transposition for stage Ib squamous cell cervical cancer - lack of effects on survival rates?

Turan AT, Keskin HL, Dundar B, Gundogdu B, Ozgul N, Boran N, Tulunay G, Kose MF.

Asian Pac J Cancer Prev. 2013;14(1):133-7.

2.

Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer.

Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman LD, Wright JD.

Obstet Gynecol. 2017 Jan;129(1):139-151. doi: 10.1097/AOG.0000000000001754.

PMID:
27926642
3.
4.

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer.

Chai Y, Wang T, Wang J, Yang Y, Gao Y, Gao J, Gao S, Wang Y, Zhou X, Liu Z.

BMC Cancer. 2014 Feb 4;14:63. doi: 10.1186/1471-2407-14-63.

5.

Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy.

Chen SW, Liang JA, Yang SN, Lin FJ.

Jpn J Clin Oncol. 2003 Sep;33(9):477-81.

PMID:
14594942
6.

Ovarian function after surgical treatment for cervical cancer.

Buekers TE, Anderson B, Sorosky JI, Buller RE.

Gynecol Oncol. 2001 Jan;80(1):85-8.

PMID:
11136575
7.

Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update.

Landoni F, Colombo A, Milani R, Placa F, Zanagnolo V, Mangioni C.

J Gynecol Oncol. 2017 May;28(3):e34. doi: 10.3802/jgo.2017.28.e34. Epub 2017 Feb 24.

8.

Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma.

Kim JH, Kim HJ, Hong S, Wu HG, Ha SW.

Gynecol Oncol. 2005 Feb;96(2):407-14.

PMID:
15661229
9.

Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma.

Mabuchi S, Okazawa M, Matsuo K, Kawano M, Suzuki O, Miyatake T, Enomoto T, Kamiura S, Ogawa K, Kimura T.

Gynecol Oncol. 2012 Oct;127(1):114-20. doi: 10.1016/j.ygyno.2012.06.021. Epub 2012 Jun 21.

PMID:
22728518
10.

The role of ovarian transposition in patients with early stage cervical cancer--two case reports.

Salakos N, Bakalianou K, Iavazzo C, Paltoglou G, Papadias K, Liapis A, Kondi-Pafiti A.

Eur J Gynaecol Oncol. 2008;29(3):280-1.

PMID:
18592796
11.

Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.

Zheng M, Huang L, Liu JH, Xiong Y, Li JD, Huang X, He L, Ren YF, Wang HY.

J Surg Oncol. 2011 Oct;104(5):480-5. doi: 10.1002/jso.21956. Epub 2011 May 2.

PMID:
21538358
12.

Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.

Sandadi S, Tanner EJ, Khoury-Collado F, Kostolias A, Makker V, Chi DS, Sonoda Y, Alektiar KM, Barakat RR, Abu-Rustum NR.

Int J Gynecol Cancer. 2013 Mar;23(3):553-8. doi: 10.1097/IGC.0b013e3182849d53.

PMID:
23392402
13.

Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix.

Roberts KB, Urdaneta N, Vera R, Vera A, Gutierrez E, Aguilar Y, Ott S, Medina I, Sempere P, Rockwell S, Sartorelli AC, Fischer DB, Fischer JJ.

Int J Cancer. 2000 Aug 20;90(4):206-23.

14.

Pattern of failure and long-term morbidity in patients undergoing postoperative radiotherapy for cervical cancer.

Jain P, Hunter RD, Livsey JE, Coyle C, Kitchener HC, Swindell R, Davidson SE.

Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1839-45.

PMID:
17009980
15.

[Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].

Hu JL, Wu LY, Li N, Li XG, Huang MN, Zhang R.

Zhonghua Fu Chan Ke Za Zhi. 2012 Jun;47(6):452-7. Chinese.

PMID:
22932113
16.

Adjuvant radiotherapy following radical hysterectomy for patients with early-stage cervical carcinoma (1984-1996).

Snijders-Keilholz A, Hellebrekers BW, Zwinderman AH, van de Vijver MJ, Trimbos JB.

Radiother Oncol. 1999 May;51(2):161-7.

PMID:
10435808
17.

Evaluation of treatment results and prognostic factors in early-stage cervical carcinoma patients treated with postoperative radiotherapy or radiochemotherapy.

Demirci S, Ozsaran Z, Ozsaran A, Yavas F, Demircioglu B, Hanhan M, Dikmen Y, Aras AB.

Eur J Gynaecol Oncol. 2012;33(1):62-7.

PMID:
22439408
18.

[Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].

Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Ganansia V, Bernard A, Antoine JM, Jannet D, Lhuillier PE, Uzan M, Genestie C, Antoine M, Jamali M, Milliez J, Uzan S, Blondon J.

Cancer Radiother. 2002 Jun;6(4):217-37. French.

PMID:
12224488
19.

The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.

Yin YJ, Li HQ, Sheng XG, Du XL, Wang C, Lu CH, Pan CX.

Int J Gynecol Cancer. 2015 Jul;25(6):1058-65. doi: 10.1097/IGC.0000000000000360.

PMID:
25647254
20.

Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.

Qin T, Zhen J, Zhou M, Wu H, Ren R, Qu B, Wang H.

Int J Surg. 2016 Jun;30:121-5. doi: 10.1016/j.ijsu.2016.04.038. Epub 2016 Apr 27.

PMID:
27131759

Supplemental Content

Support Center